Search Results - "Gordon, Maxwell" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

KEYNOTE-048: Progression after the next line of therapy following pembrolizumab (P) or P plus chemotherapy (P+C) vs EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

KEYNOTE-048: Progression after the next line of therapy following pembrolizumab (P) or P plus chemotherapy (P+C) vs EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

by Harrington, Kevin Joseph, Rischin, Danny, Greil, Richard, Soulieres, Denis, Tahara, Makoto, Castro, Gilberto, Psyrri, Amanda, Baste, Neus, Neupane, Prakash C., Bratland, Åse, Fuereder, Thorsten, Hughes, Brett Gordon Maxwell, Mesia, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Wan Ishak, Wan Zamaniah, Zhang, Yayan, Gumuscu, Burak, Swaby, Ramona F., Burtness, Barbara
Published in Journal of clinical oncology (20.05.2020)

Get full text

Journal Article

An unexpected zoonosis: pulmonary dirofilaria infection mimicking pulmonary neoplasm

An unexpected zoonosis: pulmonary dirofilaria infection mimicking pulmonary neoplasm

by Maxwell, Gordon, Sood, Jaideep, Allpress, Stephen
Published in Respirology case reports (01.11.2019)

Get full text

Journal Article

Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

by Rischin, Danny, Harrington, Kevin J., Greil, Richard, Soulieres, Denis, Tahara, Makoto, de Castro, Gilberto, Psyrri, Amanda, Baste, Neus, Neupane, Prakash C., Bratland, Ase, Fuereder, Thorsten, Hughes, Brett Gordon Maxwell, Mesia, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Wan Ishak, Wan Zamaniah, Zhang, Yayan, Jin, Fan, Gumuscu, Burak, Burtness, Barbara
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

Introduction of portable bedside echocardiography to acute general medicine

Introduction of portable bedside echocardiography to acute general medicine

by Maxwell, Allan Gordon, Jardine, David L.
Published in Internal medicine journal (01.08.2019)

Get full text

Journal Article

$Safety and clinical activity of adenosine A2a receptor (A2aR) antagonist, CPI-444, in anti-PD1/PDL1 treatment-refractory renal cell (RCC) and non-small cell lung cancer (NSCLC) patients$

Safety and clinical activity of adenosine A2a receptor (A2aR) antagonist, CPI-444, in anti-PD1/PDL1 treatment-refractory renal cell (RCC) and non-small cell lung cancer (NSCLC) patients

by Fong, Lawrence, Forde, Patrick M., Powderly, John D., Goldman, Jonathan Wade, Nemunaitis, John J., Luke, Jason John, Hellmann, Matthew David, Kummar, Shivaani, Doebele, Robert Charles, Mahadevan, Daruka, Gadgeel, Shirish M., Hughes, Brett Gordon Maxwell, Markman, Ben, Riese, Matthew John, Brody, Joshua, Emens, Leisha A., McCaffery, Ian, Miller, Richard Alan, Laport, Ginna
Published in Journal of clinical oncology (20.05.2017)

Get full text

Journal Article

Efficacy and safety of the ALK inhibitor alectinib in ALK + non-small-cell lung cancer (NSCLC) patients who have failed prior crizotinib: An open-label, single-arm, global phase 2 study (NP28673)

Efficacy and safety of the ALK inhibitor alectinib in ALK + non-small-cell lung cancer (NSCLC) patients who have failed prior crizotinib: An open-label, single-arm, global phase 2 study (NP28673)

by Ou, Sai-Hong Ignatius, Ahn, Jin Seok, De Petris, Luigi, Govindan, Ramaswamy, Yang, James Chih-Hsin, Hughes, Brett Gordon Maxwell, Lena, Hervé, Moro-Sibilot, Denis, Bearz, Alessandra, Ramirez, Santiago Viteri, Mekhail, Tarek, Spira, Alexander I., Zeaiter, Ali Hassan, Bordogna, Walter, Balas, Bogdana, Golding, Sophie, Morcos, Peter N., Kim, Dong-Wan
Published in Journal of clinical oncology (20.05.2015)

Get full text

Journal Article

Clinical utility and tolerability of linagliptin in diabetic patients

Clinical utility and tolerability of linagliptin in diabetic patients

by Maxwell, Lauralee Gordon, McFarland, M Shawn
Published in Drug, healthcare and patient safety (01.01.2013)

Get full text

Journal Article

AIDS, aneuploidy and oncogenes

AIDS, aneuploidy and oncogenes

by Gordon, Maxwell
Published in Nature biotechnology (01.09.2004)

Get full text

Journal Article

Evaluating the prognostic significance of significant weight loss in patients with stage III non-small cell lung cancer (NSCLC) undergoing definitive chemoradiation (CRT) after FDG-PET staging

Evaluating the prognostic significance of significant weight loss in patients with stage III non-small cell lung cancer (NSCLC) undergoing definitive chemoradiation (CRT) after FDG-PET staging

by Senko, Clare, Moore, Julie, Hay, Karen, Lwin, Zarnie, Pratt, Gary, Fong, Kwun, Hughes, Brett Gordon Maxwell
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

An audit of patients with a diagnosis of idiopathic pulmonary fibrosis (IPF) in Canterbury, New Zealand

An audit of patients with a diagnosis of idiopathic pulmonary fibrosis (IPF) in Canterbury, New Zealand

by Fulforth, James
Published in New Zealand medical journal (26.07.2019)

Get full text

Journal Article

Pembrolizumab (pembro) for locally advanced (LA) or recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (cSCC): Long-term results of the phase 2 KEYNOTE-629 study

Pembrolizumab (pembro) for locally advanced (LA) or recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (cSCC): Long-term results of the phase 2 KEYNOTE-629 study

by Muñoz Couselo, Eva, Hughes, Brett Gordon Maxwell, Mortier, Laurent, Grob, Jean-Jacques, Gutzmer, Ralf, Roshdy, Osama, Gonzalez Mendoza, Rene Lazaro, Schachter, Jacob, Arance, Ana Maria, Grange, Florent, Meyer, Nicolas, Joshi, Abhishek Jagdish, Billan, Salem, Ojavee, Sven Erik, Yuan, Jianda, Gumuscu, Burak, Bratland, Åse
Published in Journal of clinical oncology (01.06.2024)

Get full text

Journal Article

A phase 2 study of de-escalation in resectable, locally advanced cutaneous squamous cell carcinoma (cSCC) with the use of neoadjuvant pembrolizumab: De-Squamate

A phase 2 study of de-escalation in resectable, locally advanced cutaneous squamous cell carcinoma (cSCC) with the use of neoadjuvant pembrolizumab: De-Squamate

by Ladwa, Rahul, Lee, Jenny HJ, Porceddu, Sandro V, McGrath, Margaret Louise, Cooper, Caroline, Liu, Howard, Gupta, Ruta, Cuscaden, Claire, Nottage, Michelle K., Clark, Jonathan, Le, Dieu, Pauley, Marketa, Gonzalez-Cruz, Jazmina, Frazer, Ian, Hughes, Brett Gordon Maxwell, Panizza, Benedict J
Published in Journal of clinical oncology (01.06.2024)

Get full text

Journal Article

Efficacy of programmed cell death protein 1 (PD1) inhibitors in cutaneous squamous cell carcinoma (cSCC) patients with large nerve-perineural invasion (LN-PNI): A multicenter retrospective study

Efficacy of programmed cell death protein 1 (PD1) inhibitors in cutaneous squamous cell carcinoma (cSCC) patients with large nerve-perineural invasion (LN-PNI): A multicenter retrospective study

by Shrestha, Prajwol, Ladwa, Rahul, Heller, Gillian, Low, Tsu-Hui (Hubert), Palme, Carsten, Shannon, Kerwin Frank, Briscoe, Karen P., Hayat, Faisal, Clark, Jonathan, Gupta, Ruta, Hughes, Brett Gordon Maxwell, Lee, Jenny HJ
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

Hospital admissions due to immuno-oncology therapy associated toxicity: A retrospective analysis at two tertiary oncology centres

Hospital admissions due to immuno-oncology therapy associated toxicity: A retrospective analysis at two tertiary oncology centres

by Allen, Michael J, Schmidt, Andrew, Lwin, Zarnie, Hughes, Brett Gordon Maxwell
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

Psychosocial impacts of COVID-19 on oncology workforces: Metro versus regional Australia

Psychosocial impacts of COVID-19 on oncology workforces: Metro versus regional Australia

by Ahern, Elizabeth Stephanie, Gasper, Harry Michael, Chan, Bryan, Roberts, Natasha Anne, Hughes, Brett Gordon Maxwell, Wyld, David, Kennedy, Glen, Eastgate, Melissa A., Lwin, Zarnie
Published in Journal of clinical oncology (10.10.2020)

Get full text

Journal Article

Emotional impact of COVID-19 preparations on metro and regional cancer workforces in Queensland Australia: "We are all in this together "

Emotional impact of COVID-19 preparations on metro and regional cancer workforces in Queensland Australia: "We are all in this together "

by Roberts, Natasha Anne, Chan, Bryan, Ahern, Elizabeth Stephanie, Gasper, Harry Michael, Kennedy, Glen, Hughes, Brett Gordon Maxwell, Wyld, David, Eastgate, Melissa A., Lwin, Zarnie
Published in Journal of clinical oncology (10.10.2020)

Get full text

Journal Article

Preoperative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC) (POPCORN)

Preoperative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC) (POPCORN)

by Ahern, Elizabeth Stephanie, Cubitt, Annette, Ballard, Emma, Teng, Michele W.L., Dougall, William C., Smyth, Mark J., Hughes, Brett Gordon Maxwell
Published in Journal of clinical oncology (10.03.2019)

Get full text

Journal Article

Intracranial efficacy of sotorasib versus docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC): Practice-informing data from a global, phase 3, randomized, controlled trial (RCT)

Intracranial efficacy of sotorasib versus docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC): Practice-informing data from a global, phase 3, randomized, controlled trial (RCT)

by Dingemans, Anne-Marie C., Syrigos, Konstantinos, Livi, Lorenzo, Paulus, Astrid, Kim, Sang-We, Chen, Yuanbin, Felip, Enriqueta, Griesinger, Frank, Ohashi, Kadoaki, Zalcman, Gerard, Hughes, Brett Gordon Maxwell, Sorensen, Jens Benn, Blais, Normand, Ferreira, Carlos G. M., Lindsay, Colin R, Dziadziuszko, Rafal, Ward, Patrick J., Obiozor, Cynthia Chinedu, Wang, Yang, Peters, Solange
Published in Journal of clinical oncology (10.06.2023)

Get full text

Journal Article

Durvalumab with chemotherapy as first line treatment in advanced pleural mesothelioma: A phase 3, randomised trial (DREAM3R)

Durvalumab with chemotherapy as first line treatment in advanced pleural mesothelioma: A phase 3, randomised trial (DREAM3R)

by Forde, Patrick M., Nowak, Anna K., Hughes, Brett Gordon Maxwell, Kok, Peey Sei, Brown, Chris, Sun, Zhuoxin, Anagnostou, Valsamo, O'Byrne, Ken, Yip, Sonia, Cook, Alistair, Lesterhuis, Willem Joost, Pavlakis, Nick, Brahmer, Julie R., Kindler, Hedy L., Tsao, Anne S., Zauderer, Marjorie Glass, Ramalingam, Suresh S., Stockler, Martin R.
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

CD68+ tumor-associated myeloid cells as the target of adenosine-induced gene products and predictor of response to adenosine blockade with ciforadenant (cifo) in renal cell cancer (RCC)

CD68+ tumor-associated myeloid cells as the target of adenosine-induced gene products and predictor of response to adenosine blockade with ciforadenant (cifo) in renal cell cancer (RCC)

by Voss, Martin H, Hotson, Andrew N., Willingham, Stephen, Hughes, Brett Gordon Maxwell, Merchan, Jaime R., Fong, Lawrence, Chu, Michael, George, Saby, Munneke, Brian, Mobasher, Mehrdad, Miller, Richard A.
Published in Journal of clinical oncology (20.05.2020)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[15]